Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 7 | 2020 | 949 | 1.160 |
Why?
|
RNA, Neoplasm | 3 | 2020 | 747 | 1.120 |
Why?
|
Cell Separation | 2 | 2020 | 1718 | 0.830 |
Why?
|
Catatonia | 3 | 2024 | 181 | 0.510 |
Why?
|
Patient Admission | 1 | 2021 | 1364 | 0.430 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3236 | 0.410 |
Why?
|
Schools | 1 | 2021 | 1495 | 0.400 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 938 | 0.360 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2326 | 0.290 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4353 | 0.230 |
Why?
|
Neoplasms | 4 | 2021 | 22350 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4056 | 0.210 |
Why?
|
RNA, Messenger | 1 | 2017 | 12791 | 0.190 |
Why?
|
Midwestern United States | 1 | 2021 | 70 | 0.190 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 404 | 0.170 |
Why?
|
Drug Eruptions | 1 | 2021 | 335 | 0.150 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 369 | 0.140 |
Why?
|
Androstenes | 1 | 2018 | 177 | 0.130 |
Why?
|
Exanthema | 1 | 2021 | 502 | 0.130 |
Why?
|
Hep G2 Cells | 1 | 2017 | 378 | 0.130 |
Why?
|
Brain Diseases | 1 | 2022 | 1552 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2039 | 0.100 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 426 | 0.100 |
Why?
|
Hepatitis B, Chronic | 1 | 2017 | 413 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4891 | 0.100 |
Why?
|
RNA | 2 | 2018 | 2715 | 0.090 |
Why?
|
Melanoma | 2 | 2021 | 5700 | 0.090 |
Why?
|
Precancerous Conditions | 1 | 2017 | 980 | 0.080 |
Why?
|
Liver Diseases | 1 | 2018 | 1303 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3212 | 0.080 |
Why?
|
Hospitalization | 3 | 2024 | 10823 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4559 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4215 | 0.070 |
Why?
|
Cell Lineage | 1 | 2017 | 2572 | 0.070 |
Why?
|
Inpatients | 3 | 2024 | 2565 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2018 | 3691 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1960 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 8066 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2534 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3666 | 0.060 |
Why?
|
Humans | 14 | 2024 | 766766 | 0.050 |
Why?
|
United States | 5 | 2024 | 72951 | 0.050 |
Why?
|
Aged | 5 | 2024 | 171343 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13640 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21525 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13278 | 0.050 |
Why?
|
Middle Aged | 6 | 2024 | 223257 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21162 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15416 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26310 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 24295 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40149 | 0.040 |
Why?
|
Female | 7 | 2024 | 396520 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5861 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 59939 | 0.040 |
Why?
|
Male | 6 | 2024 | 364142 | 0.040 |
Why?
|
Risk Factors | 2 | 2021 | 74881 | 0.030 |
Why?
|
Adolescent | 2 | 2024 | 88904 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2012 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 81635 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223307 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8621 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1089 | 0.020 |
Why?
|
Length of Stay | 1 | 2024 | 6490 | 0.020 |
Why?
|
Psychotic Disorders | 1 | 2024 | 3276 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3465 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3888 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2430 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18397 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6512 | 0.020 |
Why?
|
Chronic Disease | 1 | 2018 | 9357 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17088 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36461 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42577 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22248 | 0.010 |
Why?
|
Child | 1 | 2024 | 80668 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59550 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54871 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81889 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65273 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168930 | 0.000 |
Why?
|
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore